Additionally, earlier studies have shown that claudin-1 downregulation was related to disease recurrence and poor patient survival in stage II colon cancer [47] and that the decreased expression of this protein was also observed in lymph node metastases of colon carcinomas. The gene discussed is CLDN1; the disease is colon carcinoma.